Indication

Routine prevention of recurrent attacks of hereditary angioedema (HAE) in adult and adolescent patients aged 12 years and older.

Medicine details

Medicine name:
berotralstat (Orladeyo)
SMC ID:
SMC2405
Pharmaceutical company
BioCryst Pharmaceuticals
BNF chapter
Skin
Submission type
Full
Publication due date:
14 March 2022
SMC meeting date:
01 February 2022
Patient group submission deadline:
29 November 2021